Two phase 2 trials with different selective TYK2 inhibitors produce high rates of efficacy in moderate to severe plaque ...

Roche Holdings AG (OTC:RHHBY) on Thursday presented new data at the AD/PD 2025 International Conference on Alzheimer’s and ...

with the aim of assessing the dual targeting of anti-TIGIT and anti-PD-1 antibodies. However, the study’s independent data monitoring committee recommended terminating the phase 3 trial after an ...

The biotech is preparing for a single pivotal phase 3 trial, called Epic, in which adults with drug-resistant MTLE will be randomized in a double-blind design to receive either NRTX-1001 or a sham ...

Phase 4 saw TV shows folded into the MCU's interconnected ... That will complete the second of the MCU's two Sagas to date, both of which contain three Phases. If this sounds like a lot, we ...

Vaxcyte (PCVX) shared topline results from its Phase 2 dose-finding study evaluating the safety, tolerability and immunogenicity of VAX-24, ...

On Thursday, the NFL announced the offseason workout program dates for all 32 teams, and with the Chicago Bears having a new ...

This investigational treatment was generally well tolerated with no serious adverse events; fewer adverse events related to non-motor symptoms were reported in the solengepras arm Pivotal Phase 3 ...

The initiation of Delhi Metro's Phase 5, particularly the Mayur Vihar Phase 3 to Loni Border corridor, marks a significant ...

Pembrolizumab plus concurrent chemoradiotherapy shows ongoing antitumor activity after about 5 years of follow-up in patients ...

J&J, meanwhile, also reported topline results from another phase 3 trial called ICONIC-TOTAL that it said showed icotrokinra met the primary endpoint of an IGA score of 0/1 at week 16 compared to ...

Eli Lilly on Sunday said the Phase 2 study of lepodisiran, designed to lower the production of lipoprotein (a), or lp (a), met its primary endpoint, reducing lp (a) levels by an average of 93.9% over ...